|
|
- The stock is in a well-established, long-term rising trend above the technical support level at 14.86 USD
|
|
|
- The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
|
| Sector Advanced Medical Equipment & Technology - Other |
|
| | 1st jan. | Capitalisation (M$) | Investor Rating |
 |
 | PULSE BIOSCIENCES, INC. | 46.02% | 883 | - |
| |
|
|
|
| Sales 2020 |
-
-
-
|
| Net income 2020 |
-
-
-
|
| Net Debt 2020 |
-
-
-
|
| P/E ratio 2020 |
- |
| Yield 2020 |
- |
|
| Capitalization |
883 M
883 M
-
|
| Capi. / Sales 2020 |
- |
| Capi. / Sales 2021 |
340x |
| Nbr of Employees |
82 |
| Free-Float |
50,3% |
|
Upcoming event on PULSE BIOSCIENCES, INC.
Notations Surperformance© Fundamental ratings
|
Overall rating |
| Trading Rating |
- |
| Investor Rating |
- |
| Growth (Revenue) |
- |
| Valuation |
- |
| Finances |
- |
| Profitability |
- |
| Earnings quality |
- |
| Business Predictability |
- |
| P/E ratio |
- |
| Potential |
|
| Yield |
- |
| Consensus |
- |
| 7 days EPS revision |
- |
| 4 months EPS revision |
- |
| 1 year EPS revision |
- |
| 4 months Revenue revision |
- |
| 1 year Revenue revision |
- |
Technical ratings
| Short Term Timing |
|
| Middle Term Timing |
|
| Long Term Timing |
|
| RSI |
|
| Bollinger Spread |
|
| Unusual Volumes |
|
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
